Work

Figure S6 from A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate

Year: 2023

Type: other

Abstract: BO-264 impairs tumor growth better than SPL-B does at the same dose.

DOI: 10.1158/1535-7163.22520544.v1

Authors: Ozge Akbulut, Deniz Lengerli, Ozge Saatci, Elif Duman, Urartu O.S. Seker, Aynur Isik, Aytekin Akyol, Burcu Caliskan, Erden Banoglu, Ozgur Sahin

Language: English

Topic: Microtubule and mitosis dynamics

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362490890

Cites:

Cited by:

Related to: 10